Old Mission Capital
TLSIW icon

Old Mission Capital’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

Old Mission Capital’s Portfolio TLSIW Stock Details TLSIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-12,479
Closed -$935 – 1710
2022
Q4 		$935 Buy
12,479
+1,219
+11% +$83 ﹤0.01% 1363
2022
Q3 		$1K Buy
11,260
+595
+6% +$43 ﹤0.01% 910
2022
Q2 		$1K Buy
+10,665
New +$2.04K ﹤0.01% 1352

Other funds holding TLSIW

Magnetar Financial
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.6B AUM 113.36% 1-Year Est. Return
Polar Asset Management Partners
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
KL
KIM LLC Wichita, Kansas $1B AUM 29.68% 1-Year Est. Return
Radcliffe Capital Management
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return
Vestcor Inc
Vestcor Inc Fredericton, New Brunswick, Canada $4.05B AUM 34.56% 1-Year Est. Return
MSD Partners
MSD Partners New York $76.8M AUM 34.91% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Old Mission Capital's TLSIW Position: Q1 2023 in Review

Old Mission Capital sold out of TriSalus Life Sciences Warrant (TLSIW) in Q1 2023, closing a stake of 12,479 shares — an estimated $935 sold.

Old Mission Capital first reported a position in TLSIW in Q2 2022 and held it in 3 quarters. The position peaked at $1K in Q3 2022. 24 funds tracked by Wall St. Rank hold TLSIW as of Q1 2023.

  • Old Mission Capital reported no remaining TriSalus Life Sciences Warrant position as of Q1 2023 after selling out during the quarter.
  • Old Mission Capital sold 12,479 TriSalus Life Sciences Warrant shares in Q1 2023, an estimated $935.
  • Old Mission Capital first reported a position in TriSalus Life Sciences Warrant in Q2 2022 and held it in 3 quarters.
  • Old Mission Capital's TriSalus Life Sciences Warrant position peaked at $1K in Q3 2022.
  • 24 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q1 2023.

Based on Old Mission Capital's 13F filing for Q1 2023, filed 12 May 2023.